| Birth Day | October 01, 1955 |
| Birth Place | Amreli, Gujarat, India, India |
| Dilip Shanghvi age | 67 YEARS OLD |
| Birth Sign | Scorpio |
| Residence | Mumbai, India |
| Alma mater | University of Calcutta |
| Occupation | Founder and MD of Sun Pharmaceuticals |
| Spouse(s) | Vibha Sanghvi |
| Children | 2 |
Dilip Shanghvi, considered a prominent figure in the healthcare industry in India, is widely recognized for his entrepreneurial success and leading the pharmaceutical company, Sun Pharmaceuticals Industries Ltd. His net worth is projected to reach an impressive $15.6 billion by 2024. Shanghvi's contributions to the healthcare sector have been instrumental in providing affordable and innovative medicines, thus playing a pivotal role in enhancing access to healthcare services across the country. His entrepreneurial journey and immense wealth underline his profound impact on the healthcare landscape of India.
Our story is all about incremental growth. We"re not looking for big leaps; we prefer small jumps.
Shanghvi started Sun Pharmaceutical Industries with capital of ₹10,000 in 1982 at Vapi, with one psychiatry drug and a partner, Pradeep Ghosh. In 1997, Sun acquired Caraco Pharma, a loss-making American company, with the aim of expanding Sun's reach in the United States. Sun also acquired Israel's Taro Pharma in 2007. Shanghvi stepped down as chairman and CEO in 2012 and chose Israel Makov, formerly CEO of Teva Pharmaceuticals, as his successor; Shangvi became managing Director. In April 2014 Sun, Ranbaxy, and Daiichi Sankyo (the majority shareholder in Ranbaxy) agreed that Sun would acquire all outstanding shares of Ranbaxy for $3.2B in Sun stock and that Sun would take on $800M in Ranbaxy debt; the deal closed in March 2015 and made Sun the largest drug company in India and the fifth largest in the world, and made Daiichi the second largest shareholder in Sun.
As of August 2014, he had a net worth of $17.2 billion.
